Su Zeng

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Topics

Renal Cell Carcinoma

Signaling Pathway

Mass Spectrometry

Top Venues

Nucleic acids research

Journal of mass spectrometry : JMS

This page only lists publications with an associated author ORCID identifier.

Publications

Yang Zhang, Xingang Liu, Fengcheng Li, Jiayi Yin, Hao Yang, Xuedong Li, Xinyu Liu, Xu Chai, Tianle Niu, Su Zeng, Qingzhong Jia, Jian Zhang
INTEDE 2.0: the metabolic roadmap of drugs. Nucleic acids research (2023)
Jiayi Yin, Zhen Chen, Nanxin You, Fengcheng Li, Hanyu Zhang, Jia Xue, Hui Ma, Qingwei Zhao, Lushan Yu, Su Zeng, Jian Zhang
VARIDT 3.0: the phenotypic and regulatory variability of drug transporter. Nucleic acids research (2023)
Chunyuan Tang, Ying Zhou, Wen Sun, Haihong Hu, Yuxi Liu, Lu Chen, Fengting Ou, Su Zeng, Nengming Lin, Lushan Yu
Oncopeptide MBOP Encoded by LINC01234 Promotes Colorectal Cancer through MAPK Signaling Pathway. Cancers 14 (9) (2022)
Qingwen Xu, Yuxi Liu, Wen Sun, Tiantian Song, Xintong Jiang, Kui Zeng, Su Zeng, Lu Chen, Lushan Yu
Blockade LAT1 Mediates Methionine Metabolism to Overcome Oxaliplatin Resistance under Hypoxia in Renal Cell Carcinoma. Cancers 14 (10) (2022)
Haihong Hu, Yu Wang, Zhiyuan Qin, Wen Sun, Yanhong Chen, Jiaqi Wang, Yingying Wang, Jing Nie, Lu Chen, Sheng Cai, Lushan Yu, Su Zeng
Regulation of MRP4 Expression by circHIPK3 via Sponging miR-124-3p/miR-4524-5p in Hepatocellular Carcinoma. Biomedicines 9 (5) (2021)
Zhiyuan Qin, Haihong Hu, Wen Sun, Lu Chen, Shengnan Jin, Qingwen Xu, Yuxi Liu, Lushan Yu, Su Zeng
miR-224-5p Contained in Urinary Extracellular Vesicles Regulates PD-L1 Expression by Inhibiting Cyclin D1 in Renal Cell Carcinoma Cells. Cancers 13 (4) (2021)
Lu Wang, Yali Wang, Lushan Yu, Cuirong Sun, Yu Kang, Su Zeng
Direct differentiation of stereoisomers of ezetimibe/ambrisentan/atorvastatin and their mechanism study by electrospray ionization quadrupole time-of-flight mass spectrometry. Journal of mass spectrometry : JMS 53 (12) (2018)
Xiaoli Zheng, Yanqing Liu, Qinqin Yu, Hua Wang, Fuqing Tan, Qianying Zhu, Lingmin Yuan, Huidi Jiang, Su Zeng, Lushan Yu
Response to Comment on "Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin". Science translational medicine 9 (391) (2018)